Retatrutide reduces hunger and overeating in type 2 diabetes
Higher doses of retatrutide significantly reduced perceived hunger and overall appetite in adults with type 2 diabetes compared to placebo.
Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
Higher doses of retatrutide significantly reduced perceived hunger and overall appetite in adults with type 2 diabetes compared to placebo.
The study evaluated the effects of tirzepatide on urine albumin-to-creatinine ratio in adults with type 2 diabetes and high cardiovascular risk, finding significant reductions across all doses.
The INTERFAST-2 study evaluated the effects of intermittent fasting on individuals with insulin-treated type 2 diabetes, finding significant improvements in glycemic control and weight loss.
The PRIME2 trial evaluated a behavioral intervention for Latinx adults with prediabetes, finding significant weight loss compared to usual care.
The phase III trial investigated the effects of Enavogliflozin on leptin levels in type 2 diabetes patients, finding a significant decrease in leptin levels.
This study investigated the effects of time-restricted eating on mitochondrial bioenergetics in individuals at high risk of type 2 diabetes, finding no significant differences.
This study investigated the effects of magnesium and potassium supplementation on insomnia in diabetic patients, finding significant improvements in insomnia severity and hormonal levels.
This study investigated the effects of purified cafestol on insulin sensitivity and metabolic parameters in healthy individuals with increased waist circumference, finding significant reductions in body weight and visceral fat volume.
This study investigated the effects of asparagus powder supplementation on glycemic control in overweight and obese adults, revealing mixed outcomes on various metabolic parameters.
This randomized controlled trial evaluated the effects of quercetin on patients with type 2 diabetes receiving non-insulin medications, finding significant improvements in several health outcomes.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.